#Fremanezumab-vfrm
LightNews LightNews
aria.labeledrude.online
i know that "drugs have weird names" is hack material

but for fuck's sake,
Calcitonin gene-related peptides (CGRP) monoclonal antibodies like eptinezumab-jjmr (Vyepti), erenumab-aooe (Aimovig), fremanezumab-vfrm (Ajovy), and galcanezumab-gnlm (Emgality)
September 18, 2026 at 12:27 AM
isagel.bsky.social
Faefyre takes Ajovy (fremanezumab-vfrm), a monoclonal antibody that is one of a number of CGRP-inhibiting meds in the new generation of migraine meds. It’s supposed to prevent attacks in people with chronic migraines.
August 5, 2026 at 9:08 PM
contemppeds.bsky.social
#FDA approval news:

The federal agency has approved fremanezumab‑vfrm (Ajovy; Teva Pharmaceuticals) injection for the preventive treatment of episodic migraine in pediatric patients age 6 years and older who weigh at least 45 kg.

Full details: www.contemporarypediatrics.com/view/fda-app...
August 5, 2025 at 10:20 PM
serenaorr.bsky.social
FDA has approved #fremanezumab for #migraine #prevention in #children and #adolescents with #episodic #migraine ir.tevapharm.com/news-and-eve...
FDA Approves Expanded Indication for AJOVY® (fremanezumab-vfrm), The First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine
FDA approves single-dose AJOVY ® (fremanezumab-vfrm) injection for the preventive treatment of episodic migraine in children and adolescents aged 6-17 who weigh 45 kilograms or more, offering a long-a...
ir.tevapharm.com
August 16, 2025 at 6:46 PM
affordablerxor.bsky.social
The #Oregon #PDAB is meeting to review: #Trelegy, #Eliquis, #Xarelto, #Cosentyx, & #Creon on Aug. 20 at 8 am!

If you or someone you know has taken any of these (or any others on their list), they need to hear from you! Send a letter/sign up to speak at bit.ly/or-pdab-comment
The Oregon Prescription Drug Affordability Board (PDAB) is reviewing high-cost drugs that may strain Oregon patients or our health care system. They want to hear your experience with high costs on ANY of the prescription drugs on their review list. Use the website below to share: bit.ly/or-pdab-comment On August 20, the Oregon PDAB will review: Trelegy* (Fluticasone furoate; Umeclidinum bromide; Vilanterol trifenatate) Eliquis* (Apixaban) Xarelto (Rivaroxaban) Cosentyx (Secukinumab) Creon (Pancrelipase [Amylase; Lipase; Protease]) * = No generic currently avaiable PDAB Has Already Reviewed: Vraylar* (Cariprazine HCl ) Entresto (Sacubitril; Valsartan) Ajovy (Fremanezumab-vfrm) Emgality (Galcanezumab-gnlm) Nurtec (Rimegepant/ rimegepant sulfate) Ubrelvy* (Ubrogepant) *=no generic currently available you can still share your story about these drugs until November 19
August 5, 2025 at 6:01 PM
affordablerxor.bsky.social
The Oregon Prescription Drug Affordability Board is reviewing #Ajovy (Generic: #Fremanezumab-vfrm) on July 16 starting at 9 AM.

If you or someone you know has taken this medication, consider sharing your experience.

Public comment form: dfr.oregon.gov/pdab/Pages/p...

#OCAP #HealthPolicy
Do you take or have you taken: Ajovy? Generic: Fremanezumab-vfrm. Therapy Class: Migraine product. Consider sharing your story with the Oregon Prescription Drug Affordability Board on July 16. The OR PDAB is reviewing high-cost drugs that may strain OR patients or our healthcare system. PDAB’s 1st Review Will Be Of: Vraylar (Cariprazine HCl) Entresto (Sacubitril; Valsartan) Ajovy (Fremanezumab-vfrm) Emgality (Galcanezumab-gnlm) Nurtec (Rimegepant/ rimegepant sulfate) Ubrelvy (Ubrogepant) Your Voice Matters! If you have taken any of these medications consider sharing your story at the July 16 PDAB meeting How to Share Your Experience Submit a comment - by July 14 at 9AM Speak at the meeting - sign up by July 15 at 9AM
July 11, 2025 at 11:30 PM
affordablerxor.bsky.social
The #Oregon Prescription Drug Affordability Board is reviewing #Emgality (Generic: #Galcanezumab-gnlm) on July 16 starting at 9 AM.

If you or someone you know has taken this medication, please consider sharing your experience.

Public comment dfr.oregon.gov/pdab/Pages/p...
#OCAP #HealthPolicy
Do you take or have you taken: Emgality? Generic: Galcanezumab-gnlm. Therapy Class: Migraine product. Consider sharing your story with the Oregon Prescription Drug Affordability Board on July 16. The OR PDAB is reviewing high-cost drugs that may strain OR patients or our healthcare system. PDAB’s 1st Review Will Be Of: Vraylar (Cariprazine HCl) Entresto (Sacubitril; Valsartan) Ajovy (Fremanezumab-vfrm) Emgality (Galcanezumab-gnlm) Nurtec (Rimegepant/ rimegepant sulfate) Ubrelvy (Ubrogepant) Your Voice Matters! If you have taken any of these medications consider sharing your story at the July 16 PDAB meeting How to Share Your Experience Submit a comment - by July 14 at 9AM Speak at the meeting - sign up by July 15 at 9AM
July 11, 2025 at 4:45 PM
affordablerxor.bsky.social
The Oregon Prescription Drug Affordability Board is reviewing #Entresto (Generic: #Sacubitril , #Valsartan) on July 16 starting at 9 AM.

If you or someone you know has taken this medication, consider sharing your experience. Public comment: dfr.oregon.gov/pdab/Pages/p...

#OCAP #HealthPolicy
Do you take or have you taken: Entresto? Generic: Sacubitril; Valsartan. Therapy Class: Cardiovascular agents – misc. Consider sharing your story with the Oregon Prescription Drug Affordability Board on July 16. The OR PDAB is reviewing high-cost drugs that may strain OR patients or our healthcare system. PDAB’s 1st Review Will Be Of: Vraylar (Cariprazine HCl) Entresto (Sacubitril; Valsartan) Ajovy (Fremanezumab-vfrm) Emgality (Galcanezumab-gnlm) Nurtec (Rimegepant/ rimegepant sulfate) Ubrelvy (Ubrogepant) Your Voice Matters! If you have taken any of these medications consider sharing your story at the July 16 PDAB meeting How to Share Your Experience Submit a comment - by July 14 at 9AM Speak at the meeting - sign up by July 15 at 9AM
July 10, 2025 at 6:28 PM
affordablerxor.bsky.social
The #Oregon Prescription Drug Affordability Board is reviewing #Nurtec (Generic: #Rimegepant/ #RimegepantSulfate) on July 16 starting at 9 AM.

If you or someone you know has taken this medication, consider sharing your experience. Public comment: dfr.oregon.gov/pdab/Pages/p...

#OCAP #HealthPolicy
Do you take or have you taken: Nurtec? Generic: Rimegepant/rimegepant sulfate Therapy Class: Migraine product Consider sharing your story with the Oregon Prescription Drug Affordability Board on July 16. The OR PDAB is reviewing high-cost drugs that may strain OR patients or our healthcare system. PDAB’s 1st Review Will Be Of: Vraylar (Cariprazine HCl) Entresto (Sacubitril; Valsartan) Ajovy (Fremanezumab-vfrm) Emgality (Galcanezumab-gnlm) Nurtec (Rimegepant/ rimegepant sulfate) Ubrelvy (Ubrogepant) Your Voice Matters! If you have taken any of these medications consider sharing your story at the July 16 PDAB meeting How to Share Your Experience Submit a comment - by July 14 at 9AM Speak at the meeting - sign up by July 15 at 9AM
July 9, 2025 at 11:10 PM
affordablerxor.bsky.social
The #Oregon Prescription Drug Affordability Board is reviewing #Ubrelvy (Generic: Ubrogepant) on July 16 starting at 9 AM.

If you or someone you know has taken this medication, please consider sharing your experience.

Public comment form: dfr.oregon.gov/pdab/Pages/p...

#OCAP #HealthPolicy
Do you take or have you taken: Ubrelvy? Generic: Ubrogepant Therapy Class: Migraine product Consider sharing your story with the Oregon Prescription Drug Affordability Board on July 16. The OR PDAB is reviewing high-cost drugs that may strain OR patients or our healthcare system. PDAB’s 1st Review Will Be Of: Vraylar (Cariprazine HCl) Entresto (Sacubitril; Valsartan) Ajovy (Fremanezumab-vfrm) Emgality (Galcanezumab-gnlm) Nurtec (Rimegepant/ rimegepant sulfate) Ubrelvy (Ubrogepant) Your Voice Matters! If you have taken any of these medications consider sharing your story at the July 16 PDAB meeting How to Share Your Experience Submit a comment - by July 14 at 9AM Speak at the meeting - sign up by July 15 at 9AM
July 8, 2025 at 9:10 PM
affordablerxor.bsky.social
The #Oregon Prescription Drug Affordability Board is reviewing #Vraylar (Generic: #CariprazineHCl) on July 16 starting at 9 AM.

If you or someone you know takes or has taken this medication, consider sharing your experience.

Public comment: dfr.oregon.gov/pdab/Pages/p...

#OCAP #HealthPolicy
Do you take or have you taken: Vraylar? Generic: Cariprazine HCl. Therapy Class: Antipsychotics & Antimaic agents. Consider sharing your story with the Oregon Prescription Drug Affordability Board on July 16. The Oregon Prescription Drug Affordability Board (PDAB) is reviewing high-cost drugs that may strain Oregon patients or our health care system. PDAB’s First Review Will Be Of: Vraylar (Cariprazine HCl ) Entresto (Sacubitril; Valsartan) Ajovy (Fremanezumab-vfrm) Emgality (Galcanezumab-gnlm) Nurtec (Rimegepant/ rimegepant sulfate) Ubrelvy (Ubrogepant) Your Voice Matters! If you have taken any of these medications consider sharing your story at the July 16 PDAB meeting How to Share Your Experience Submit a comment - by July 14 at 9AM Speak at the meeting - sign up by July 15 at 9AM
July 7, 2025 at 7:23 PM
medicalxpress.com.web.brid.gy
Fda approves Ajovy for migraine prevention in children and teens
The U.S. Food and Drug Administration has approved the single-dose Ajovy (fremanezumab-vfrm) injection for the preventive treatment of episodic migraine in children and adolescents.
medicalxpress.com
August 11, 2025 at 9:42 PM
mdspirenews.bsky.social
A newly approved migraine prevention option is now available for pediatric patients aged 6 to 17, offering CGRP-targeted therapy previously limited to adults. Learn more about the clinical implications for your practice.

#PediatricNeurology #MigrainePrevention

conexiant.com/neurology/ar...
New Preventive Option Approved for Pediatric Migraine
The FDA has approved Ajovy (fremanezumab-vfrm) for preventive treatment of episodic migraine in pediatric patients aged 6 to 17 years weighing 45 kg or more, expanding its use beyond adults.
conexiant.com
August 6, 2025 at 8:24 PM
healthday.bsky.social
The #FDA has approved the single-dose Ajovy (fremanezumab-vfrm) injection for the preventive treatment of episodic migraine in children and adolescents.
www.healthday.com/healthpro-ne...
FDA Approves Ajovy for Migraine Prevention in Children and Teens
MONDAY, Aug. 11, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved the single-dose Ajovy (fremanezumab-vfrm) injection for the prevent
www.healthday.com
August 12, 2025 at 1:56 PM
newsmax.com
FDA Approves Migraine Prevention Drug for Kids
FDA Approves Migraine Prevention Drug for Kids
The U.S. Food and Drug Administration has approved the single-dose Ajovy (fremanezumab-vfrm) injection for the preventive treatment of episodic migraine in children and adolescents. In the United States, one in 10 children and adolescents experience migraine, a common but...
dlvr.it
August 11, 2025 at 9:06 PM